AR and benign prostatic hyperplasia: These results suggest that the leaves of AR and its caffeoyl derivatives and caffeoyl secoiridoid, especially grandifloroside (7) (the first isolated secoiridoid from this plant) might be developed as anti-oxidant, anti-inflammatory, and potential therapeutic agents for the treatment of BPH.